Michal Blaszczyk
Overview
Explore the profile of Michal Blaszczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubanek A, Renke M, Godlewska B, Paul P, Przybylak M, Kowalska A, et al.
Front Psychiatry
. 2024 Aug;
15:1410252.
PMID: 39109362
Background: Depressive disorder is common among haemodialysis patients. The purpose of this study was to explore approaches to diagnosing depression in the context of a real-life setting, with the view...
2.
Cichocki P, Plachcinska A, Blaszczyk M, Adamczewski Z
Sci Rep
. 2024 Jul;
14(1):16671.
PMID: 39030217
Dynamic assessment of myocardial blood flow (MBF) and myocardial flow reserve (MFR) provides additional information that can improve diagnostic accuracy of radionuclide myocardial perfusion imaging in some clinical situations. This...
3.
El Bakali J, Blaszczyk M, Evans J, Boland J, McCarthy W, Fathoni I, et al.
Angew Chem Weinheim Bergstr Ger
. 2024 Mar;
135(17):e202300221.
PMID: 38515507
The coenzyme A (CoA) biosynthesis pathway has attracted attention as a potential target for much-needed novel antimicrobial drugs, including for the treatment of tuberculosis (TB), the lethal disease caused by...
4.
Kubanek A, Przybylak M, Paul P, Kowalska A, Blaszczyk M, Macul-Sanewska A, et al.
Acta Biochim Pol
. 2023 Dec;
70(4):979-983.
PMID: 38043099
Objective: Major depressive disorder (MDD) is one of the most common psychiatric issues in hemodialysis population. However, the research on proper diagnostic tools and its treatment is still insufficient. The...
5.
El Bakali J, Blaszczyk M, Evans J, Boland J, McCarthy W, Fathoni I, et al.
Angew Chem Int Ed Engl
. 2023 Feb;
62(17):e202300221.
PMID: 36757665
The coenzyme A (CoA) biosynthesis pathway has attracted attention as a potential target for much-needed novel antimicrobial drugs, including for the treatment of tuberculosis (TB), the lethal disease caused by...
6.
Thomas S, McCarthy W, El Bakali J, Brown K, Kim S, Blaszczyk M, et al.
Front Mol Biosci
. 2022 Jun;
9:880432.
PMID: 35712348
Anti-microbial resistance is a rising global healthcare concern that needs urgent attention as growing number of infections become difficult to treat with the currently available antibiotics. This is particularly true...
7.
Michalski T, Brosz M, Stepien J, Biernacka K, Blaszczyk M, Grabowski J
Int J Environ Res Public Health
. 2021 Dec;
18(23).
PMID: 34886564
The Coronavirus disease 2019 (COVID-19) pandemic, immigrant status and being a member of the LGBT+ community are all independent factors associated with increased stress levels. Few studies provide more complex...
8.
Cichocki P, Blaszczyk M, Cygulska K, Filipczak K, Adamczewski Z, Kusmierek J, et al.
J Pers Med
. 2021 Nov;
11(11).
PMID: 34834516
Background: Myocardial blood flow (MBF) and flow reserve (MFR) examination, especially useful in the diagnosis of multivessel coronary artery disease (CAD), can be assessed with a cadmium-zinc-telluride (CZT) SPECT gamma...
9.
Blaszczyk M, Adamczewski Z, Plachcinska A
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829477
This paper presents a review of the literature concerning the clinical application of modern semiconductor (CZT) gamma cameras in the radioinuclide diagnosis of coronary artery disease. It contains information on...
10.
Mendes V, Green S, Evans J, Hess J, Blaszczyk M, Spry C, et al.
Nat Commun
. 2021 Jan;
12(1):143.
PMID: 33420031
Coenzyme A (CoA) is a fundamental co-factor for all life, involved in numerous metabolic pathways and cellular processes, and its biosynthetic pathway has raised substantial interest as a drug target...